Loading...
Loading...
Also known as: Brahmi, Water Hyssop, BM
An Ayurvedic adaptogenic herb with strong clinical evidence for improving memory consolidation and recall, requiring 8-12 weeks of consistent use for full effects.
Bacopa Monnieri (Brahmi) is a staple of Ayurvedic medicine used for over 3,000 years as a cognitive enhancer. Modern research has validated its memory-enhancing properties across multiple randomized controlled trials.
Unlike stimulant nootropics that work immediately, Bacopa requires 8-12 weeks of daily use to reach full efficacy. Most clinical trials showing significant results used 12-week protocols. The mechanism involves actual neuronal remodeling, not just receptor modulation.
Bacosides A and B are the primary active compounds. Standardized extracts (typically 55% bacosides via Synapsa™ or BacoMind™) provide consistent dosing.
Bacosides enhance kinase activity and neuronal synthesis in the hippocampus, increase dendritic branching and length, upregulate serotonin (5-HT3A) receptor expression, and modulate acetylcholine, GABA, and dopamine systems. Antioxidant effects protect hippocampal neurons from oxidative damage.
Typical Dose
300-600mg
Frequency
Daily (with fat source)
Cycle Length
Minimum 12 weeks continuous
Half-Life
~2-4 hours (effects cumulative)
Multiple RCTs in healthy adults and elderly. Cochrane-reviewed. Strong evidence base for memory improvement. 3000+ years of traditional use.
Generally well-tolerated. Common: GI discomfort (take with food), mild fatigue initially. Rare: thyroid suppression with chronic high-dose use. May increase GI motility. Safe for long-term use at recommended doses.
A synthetic heptapeptide nootropic derived from ACTH that enhances BDNF expression, memory, and cognitive function with neuroprotective properties.
A synthetic anxiolytic peptide derived from tuftsin with anti-anxiety, cognitive-enhancing, and immune-modulating properties.
An extremely potent angiotensin IV analog that promotes neuronal connectivity and has shown remarkable cognitive-enhancing effects in preclinical models.